Operator: Good morning ladies and gentlemen and welcome to the DarioHealth First Quarter 2024 Results Conference Call. At this time, all lines are in a listen-only mode.
Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated Business-to-Business (B2B).
DarioHealth Reports First Quarter 2021 Results and Operational Highlights
USA - English
Announced acquisition of Upright Technologies, expanding into the musculoskeletal and related pain conditions markets
Generated Q1 revenue growth of 73% over Q4 2020 and 116% over Q1 2020, driven by organic growth and consolidation of Upright Technologies revenues effective February 2, 2021
GAAP gross margin was 30.1% in the first quarter, excluding acquisition related amortizations Q1 2021 product gross margin nearly doubled to 44.7% as compared to 24.2% in Q4 2020
Ended the first quarter 2021 with cash and cash equivalents of $81.1 million
Company to host conference call and webcast 8:30 am ET tomorrow.
News provided by
Share this article
Share this article